FORA Capital’s Aimmune Therapeutics AIMT Stock Holding History

FORA Capital’s Portfolio AIMT Stock Details AIMT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-8,076	Closed	-$278K	–	1208
2020 Q3	$278K	Buy	+8,076	New	+$172K	0.18%	125
2020 Q2	–	Sell	-19,094	Closed	-$275K	–	1460
2020 Q1	$275K	Buy	+19,094	New	+$488K	0.06%	370

FORA Capital's AIMT Position: Q4 2020 in Review

FORA Capital sold out of Aimmune Therapeutics (AIMT) in Q4 2020, closing a stake of 8,076 shares — an estimated $278K sold.

FORA Capital first reported a position in AIMT in Q1 2020 and held it in 2 quarters. The position peaked at $278K in Q3 2020. 0 funds tracked by Wall St. Rank hold AIMT as of Q4 2020.

FORA Capital reported no remaining Aimmune Therapeutics position as of Q4 2020 after selling out during the quarter.
FORA Capital sold 8,076 Aimmune Therapeutics shares in Q4 2020, an estimated $278K.
FORA Capital first reported a position in Aimmune Therapeutics in Q1 2020 and held it in 2 quarters.
FORA Capital's Aimmune Therapeutics position peaked at $278K in Q3 2020.
0 funds tracked by Wall St. Rank held Aimmune Therapeutics as of Q4 2020.

Based on FORA Capital's 13F filing for Q4 2020, filed 12 Feb 2021.